Central anticholinergic syndrome strikes again.
Cohen
Shaul
S
Hunter
Christine W
CW
Yanni
Baher
B
Striker
Paul
P
Hijazi
Raza H
RH
D000759:Adjuvants, Anesthesia / Q000008:administration & dosage; D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects*; D018686:Anesthetics, Intravenous / Q000009:adverse effects; D002493:Central Nervous System Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000628:therapy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D005947:Glucose / Q000008:administration & dosage; D006024:Glycopyrrolate / Q000008:administration & dosage; D006327:Heart Block / Q000139:chemically induced / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008874:Midazolam / Q000009:adverse effects; D008875:Middle Aged; D009270:Naloxone / Q000008:administration & dosage; D009292:Narcotic Antagonists / Q000008:administration & dosage; D010830:Physostigmine / Q000627:therapeutic use; D015742:Propofol / Q000009:adverse effects; D012121:Respiration, Artificial / Q000379:methods; D013577:Syndrome
D000759:Adjuvants, Anesthesia; D018686:Anesthetics, Intravenous; D002800:Cholinesterase Inhibitors; D009292:Narcotic Antagonists; D009270:Naloxone; D010830:Physostigmine; D005947:Glucose; D008874:Midazolam; D006024:Glycopyrrolate; D015742:Propofol